Researchers have launched a clinical trial at the NIH Clinical Center to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). DEX-M74, based on an NIH technology, is being developed through a collaboration between the

The NIH Office of Technology Transfer, Johns Hopkins University Technology Transfer and TTS Ltd., are pleased to announce that the 2012 edition of the Tech Transfer Summit North America (TTSNA) will take place on October 22-23, 2012. The conference will take place at at the Montgomery County

The inaugural NIH Start-up Licenses program has been so successful that the Office of Technology Transfer (OTT) had decided to extend it for another year. From the start of the program on October 1, 2011 to September 12, 2012, we have executed five licenses and have a number in the process of